(Q33323232)

25 July 2017

title

Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells (English)

1 reference

25 July 2017

Robert J Williams

4

0 references

Paul T. Francis

object named as

Paul T Francis

3

0 references

author name string

Francisco Molina-Holgado

1

1 reference

25 July 2017

Alessandra Gaeta

2

1 reference

25 July 2017

Robert C Hider

5

1 reference

25 July 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

Journal of Neurochemistry

25 July 2017

published in

1 reference

25 July 2017

volume

105

1 reference

25 July 2017

issue

6

1 reference

25 July 2017

page(s)

2466-2476

1 reference

Hydrogen peroxide mediates amyloid beta protein toxicity

25 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Neuroprotection by a novel brain permeable iron chelator, VK-28, against 6-hydroxydopamine lession in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Role of iron in neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Lipofuscin: mechanisms of age-related accumulation and influence on cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

A novel hypothesis of lipofuscinogenesis and cellular aging based on interactions between oxidative stress and autophagocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Metal complexing agents as therapies for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Hydrogen peroxide-mediated phosphorylation of ERK1/2, Akt/PKB and JNK in cortical neurones: dependence on Ca(2+) and PI3-kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Antioxidants, oxidative stress, and degenerative neurological disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Investigation into the correlation between the structure of hydroxypyridinones and blood-brain barrier permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Oxidative stress and neurodegeneration: where are we now?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Role of Protein Aggregation in Mitochondrial Dysfunction and Neurodegeneration in Alzheimer's and Parkinson's Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Pro-apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Glutathione peroxidase 1 and glutathione are required to protect mouse astrocytes from iron-mediated hydrogen peroxide toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Amyloid beta peptide, 4-hydroxynonenal and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Synuclein, dopamine and oxidative stress: co-conspirators in Parkinson's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Iron dysregulation in Alzheimer's disease: multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Metals ions and neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Iron, atherosclerosis, and neurodegeneration: a key role for cholesterol in promoting iron-dependent oxidative damage?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Models of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Novel chelators for central nervous system disorders that involve alterations in the metabolism of iron and other metal ions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Metal and inflammatory targets for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

The role of iron in beta amyloid toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Biomarkers of neurodegeneration for diagnosis and monitoring therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Oxidative stress induced-neurodegenerative diseases: the need for antioxidants that penetrate the blood brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Heme and iron metabolism: role in cerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Iron: a new target for pharmacological intervention in neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

Iron, brain ageing and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.2008.05332.X

10.1111/J.1471-4159.2008.05332.X

21 January 2018

Identifiers

DOI

1 reference

25 July 2017

1 reference